STAGE III HEPATOCELLULAR CARCINOMA AJCC V7
Clinical trials for STAGE III HEPATOCELLULAR CARCINOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III HEPATOCELLULAR CARCINOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE III HEPATOCELLULAR CARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Proton beam vs. X-Ray: which radiation is better for liver cancer?
Disease control OngoingThis study compares two radiation therapies for people with liver cancer that cannot be removed by surgery or has come back. One uses standard X-rays (photons), the other uses proton beams that stop after the tumor, possibly causing less harm to healthy tissue. The goal is to see…
Matched conditions: STAGE III HEPATOCELLULAR CARCINOMA AJCC V7
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
New drug duo shows promise for Hard-to-Treat cancers
Disease control OngoingThis early-stage study tests a combination of two drugs, guadecitabine and durvalumab, in people with advanced liver, pancreatic, bile duct, or gallbladder cancer that has spread. The goal is to find the best dose and see if the combination is safe and can shrink tumors. About 55…
Matched conditions: STAGE III HEPATOCELLULAR CARCINOMA AJCC V7
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 22, 2026 13:50 UTC